Stock Code: Guangdong Vtr Bio-Tech Co.Ltd(300381) stock abbreviation: Guangdong Vtr Bio-Tech Co.Ltd(300381)
Bond Code: 123018 bond abbreviation: profit convertible bond Announcement No.: 2022030 Guangdong Vtr Bio-Tech Co.Ltd(300381)
Correction announcement
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Guangdong Vtr Bio-Tech Co.Ltd(300381) (hereinafter referred to as “the company”) was posted on cninfo (www.cn. Info. Com. CN.) on April 12, 2022 The announcement on the resolution of the 16th meeting of the seventh board of directors (Announcement No.: 2022028) and the announcement on the adjustment of the capital increase scheme of the holding subsidiary Hunan xinhexin biomedical Co., Ltd. (Announcement No.: 2022029) are disclosed. Due to negligence, there are errors in the data input in the adjusted capital increase scheme form, which are corrected as follows:
Before correction:
(II) overview of adjusted capital increase scheme
On April 11, 2022, the company held the 16th meeting of the seventh board of directors, deliberated and passed the proposal on the adjustment of the capital increase scheme of the holding subsidiary Hunan xinhexin biomedical Co., Ltd., and agreed to change the total investment amount of the capital increase party from 524 million yuan to 494 million yuan. Two investors, Hainan shangshandianzan private venture capital fund partnership and Zhu Guoliang, withdrew from the capital increase, Hunan jiukang venture capital partnership (limited partnership), Hainan Shangshan Hongren private venture capital fund partnership (limited partnership), Shenzhen Hongdian Shengshi pharmaceutical investment partnership (limited partnership), Hunan Shengjian enterprise management service partnership (limited partnership) and Li Yiqing are added. The details of capital increase of each party are as follows:
No. name of new shareholder total investment included in registered capital included in capital reserve (RMB 10000) capital (RMB 10000)
1 Hunan alcohol Investment Industrial Development Co., Ltd. 1940000 4946667189053333
2 Hunan Sheng’an enterprise management partnership (300000 76494929235051 partnership)
3 Hunan Shengjian enterprise management service partnership 200000 50996619490034 (limited partnership)
4 CICC (Changde) venture capital in emerging industries totaling 500000 127491448725086 enterprises (limited partnership)
5. Changdejinxin No.2 medical device industry invested Shanghai Pudong Development Bank Co.Ltd(600000) 152989758470103 enterprises (limited partnership)
6 Hunan jiukang venture capital partnership (limited partnership, 200000, 509966, 19490034)
7 Hainan Shangshan Hongren private venture capital fund 100000 2549839745017 partnership (limited partnership)
8 Shenzhen Hongdian Shengshi pharmaceutical investment partnership Shanghai Pudong Development Bank Co.Ltd(600000) 152989758470103 (limited partnership)
9 li Yiqing 500000 127491448725086
Total 494 Csg Holding Co.Ltd(000012) 596152481403848
After correction:
(II) overview of adjusted capital increase scheme
On April 11, 2022, the company held the 16th meeting of the seventh board of directors, deliberated and passed the proposal on the adjustment of the capital increase scheme of the holding subsidiary Hunan xinhexin biomedical Co., Ltd., and agreed to change the total investment amount of the capital increase party from 524 million yuan to 494 million yuan. Two investors, Hainan shangshandianzan private venture capital fund partnership and Zhu Guoliang, withdrew from the capital increase, Hunan jiukang venture capital partnership (limited partnership), Hainan Shangshan Hongren private venture capital fund partnership (limited partnership), Shenzhen Hongdian Shengshi pharmaceutical investment partnership (limited partnership), Hunan Shengjian enterprise management service partnership (limited partnership) and Li Yiqing are added. The details of capital increase of each party are as follows:
No. name of new shareholder total investment included in registered capital included in capital reserve (RMB 10000) capital (RMB 10000)
1 Hunan alcohol Investment Industrial Development Co., Ltd. 1940000 4663461189336539
2. CICC (Changde) venture capital in emerging industries totaling 500000 120192348798077 enterprises (limited partnership)
3. Changdejinxin No.2 medical device industry investment Shanghai Pudong Development Bank Co.Ltd(600000) 144230758557693 enterprise (limited partnership)
4 Hunan jiukang venture capital partnership (limited partnership, 200000, 480770, 19519230)
5 Hainan Shangshan Hongren private venture capital fund 100000 2403849759616 partnership (limited partnership)
6 Shenzhen Hongdian Shengshi pharmaceutical investment partnership Shanghai Pudong Development Bank Co.Ltd(600000) 144230758557693 (limited partnership)
7 Hunan Sheng’an enterprise management partnership (285000 68509627814904 partnership)
8 Hunan Shengjian enterprise management service partnership 215000 51682720983173 (limited partnership)
9 li Yiqing 500000 120192348798077
Total 494 Shenzhen Properties & Resources Development (Group) Ltd(000011) 874998482125002
In addition to the above corrections, other contents in the original announcement remain unchanged. The Company Apologizes for the inconvenience caused to the majority of investors by this correction.
It is hereby announced.
Guangdong Vtr Bio-Tech Co.Ltd(300381) board of directors
April 13, 2022
